Susanna Tse

859 total citations
26 papers, 474 citations indexed

About

Susanna Tse is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Susanna Tse has authored 26 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Susanna Tse's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Hormonal and reproductive studies (3 papers). Susanna Tse is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Hormonal and reproductive studies (3 papers). Susanna Tse collaborates with scholars based in United States, Hong Kong and United Kingdom. Susanna Tse's co-authors include Ten‐Tsao Wong, R. Scott Obach, Michael J. Greenberg, Ernesto Callegari, E.T. Wei, Louis Leung, Vaishali Sahasrabudhe, Anne Ronan, L. David Meeker and Anthony R. Tagliaferro and has published in prestigious journals such as The Journal of Infectious Diseases, Annals of Oncology and International Journal of Pharmaceutics.

In The Last Decade

Susanna Tse

25 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susanna Tse United States	14	146	118	88	68	61	26	474
Peter Dogterom Netherlands	18	206 1.4×	153 1.3×	76 0.9×	145 2.1×	95 1.6×	41	896
Lucie Krausová Czechia	4	182 1.2×	107 0.9×	79 0.9×	35 0.5×	51 0.8×	5	494
Mithat Gunduz United States	12	192 1.3×	159 1.3×	86 1.0×	83 1.2×	157 2.6×	24	551
James E. Grace United States	13	145 1.0×	152 1.3×	82 0.9×	61 0.9×	43 0.7×	21	555
Mario Štefanović Croatia	16	266 1.8×	100 0.8×	76 0.9×	48 0.7×	29 0.5×	85	859
Monique Schmitt Switzerland	11	109 0.7×	113 1.0×	83 0.9×	74 1.1×	59 1.0×	23	607
Donald W. Everett United States	11	162 1.1×	177 1.5×	122 1.4×	55 0.8×	76 1.2×	12	753
Barbara W. LeDuc United States	13	106 0.7×	132 1.1×	57 0.6×	100 1.5×	36 0.6×	28	455
Alex Hemeryck Belgium	12	220 1.5×	204 1.7×	134 1.5×	139 2.0×	41 0.7×	15	784
Philip Worboys United Kingdom	13	143 1.0×	228 1.9×	168 1.9×	84 1.2×	78 1.3×	14	558

Countries citing papers authored by Susanna Tse

Since Specialization

Citations

This map shows the geographic impact of Susanna Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Tse more than expected).

Fields of papers citing papers by Susanna Tse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Tse. The network helps show where Susanna Tse may publish in the future.

Co-authorship network of co-authors of Susanna Tse

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Tse. A scholar is included among the top collaborators of Susanna Tse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Tse. Susanna Tse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Callegari, Ernesto, Susanna Tse, Angela C. Doran, Theunis C. Goosen, & M. Naveed Shaik. (2023). Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study. The Journal of Clinical Pharmacology. 64(1). 80–93. 2 indexed citations

Padilla, Ángel M., Wei Wang, Tsutomu Akama, et al.. (2022). Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature Microbiology. 7(10). 1536–1546. 39 indexed citations

Hu, Wenyue, Daniel J. Lettiere, Susanna Tse, et al.. (2021). Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity. Toxicological Sciences. 182(2). 183–194. 5 indexed citations

Callegari, Ernesto, Jian Lin, Susanna Tse, Theunis C. Goosen, & Vaishali Sahasrabudhe. (2020). Physiologically‐Based Pharmacokinetic Modeling of the Drug–Drug Interaction of the UGT Substrate Ertugliflozin Following Co‐Administration with the UGT Inhibitor Mefenamic Acid. CPT Pharmacometrics & Systems Pharmacology. 10(2). 127–136. 14 indexed citations

Ji, Changhua, Mausumee Guha, Xu Zhu, et al.. (2019). Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model. Chemical Research in Toxicology. 33(1). 211–222. 31 indexed citations

Thombre, Avinash G., et al.. (2019). Ex vivo (human skin) and in vivo (minipig) permeation of propylene glycol applied as topical crisaborole ointment, 2%. International Journal of Pharmaceutics. 576. 118847–118847. 9 indexed citations

Schadt, Simone, Bojan Bister, Swapan K. Chowdhury, et al.. (2018). A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the “Metabolites in Safety Testing” Regulatory Guidance. Drug Metabolism and Disposition. 46(6). 865–878. 78 indexed citations

Sawant‐Basak, Aarti, R. Scott Obach, Angela C. Doran, et al.. (2018). Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction. Drug Metabolism and Disposition. 46(7). 934–942. 6 indexed citations

Nguyen, Hoa Q., Jian Lin, Emi Kimoto, et al.. (2017). Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences. 106(9). 2758–2770. 13 indexed citations

10.

Di, Li, Robert Chambers, Sean Eckley, et al.. (2017). Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs. Journal of Pharmaceutical Sciences. 106(12). 3442–3452. 70 indexed citations

11.

Sahasrabudhe, Vaishali, Tong Zhu, Alfin D. N. Vaz, & Susanna Tse. (2015). Drug Metabolism and Drug Interactions: Potential Application to Antituberculosis Drugs. The Journal of Infectious Diseases. 211(suppl 3). S107–S114. 15 indexed citations

12.

Tse, Susanna, Louis Leung, Sangeeta Raje, et al.. (2014). Disposition and Metabolic Profiling of [14C]Cerlapirdine Using Accelerator Mass Spectrometry. Drug Metabolism and Disposition. 42(12). 2023–2032. 14 indexed citations

13.

Callegari, Ernesto, Amit S. Kalgutkar, Louis Leung, et al.. (2013). Drug Metabolites as Cytochrome P450 Inhibitors: A Retrospective Analysis and Proposed Algorithm for Evaluation of the Pharmacokinetic Interaction Potential of Metabolites in Drug Discovery and Development. Drug Metabolism and Disposition. 41(12). 2047–2055. 25 indexed citations

14.

Nichols, Alice I., Karen A. Tourian, Susanna Tse, & Jeffrey Paul. (2010). Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor. Expert Opinion on Drug Metabolism & Toxicology. 6(12). 1565–1574. 13 indexed citations

15.

Dowell, James A., et al.. (2001). Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 41(9). 979–986. 5 indexed citations

16.

Konorev, Eugene A., John E. Baker, Susanna Tse, Joy Joseph, & Balaraman Kalyanaraman. (1992). PBN traps hydroxyl radical but fails to protect heart during ischemia and reperfusion. Journal of Molecular and Cellular Cardiology. 24. 69–69. 2 indexed citations

17.

Tse, Susanna. (1991). Coffee Contains Cholinomimetic Compound Distinct from Caffeine. I: Purification and Chromatographic Analysis. Journal of Pharmaceutical Sciences. 80(7). 665–669. 7 indexed citations

18.

Mak, I. Tong, et al.. (1990). Oxygen radical-mediated injury of myocytes-protection by propranolol. Journal of Molecular and Cellular Cardiology. 22(6). 687–695. 23 indexed citations

19.

Tse, Susanna & E.T. Wei. (1986). Inhibition of the shake response in rats by adenosine and 2-chloroadenosine. Psychopharmacology. 90(3). 322–6. 18 indexed citations

20.

Wong, Ten‐Tsao & Susanna Tse. (1984). Cold acclimation increases physiological responsiveness to intraventricular injection of β‐endorphin in pentobarbital anaesthetized rats. International journal of peptide & protein research. 24(1). 74–78. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact